MANAGEMENT OF HAEMATOLOGICAL PATIENTS TREATED WITHCARDIOTOXIC DRUG

  • Jure Dolenc
  • Mirta Koželj
  • Samo Zver

Abstract

BACKGROUND Recent advances in the treatment of malign haematological deseases with chemotherapyhave led to significant improvement in prognosis and quality of life of the pacients. Thesame drugs can lead to development of serious cardiac side effects, especially the syndromeof heart failure. Anthracycline drugs are best known for their cardiotoxicity, the role ofother drugs is less well understood. CONCLUSIONS Predisposing factors to cardiotoxicity should be taken into consideration when dealingwith such pacients. Careful history, clinical examination, electrocardiography, echocardiography and NT-proBNP measurement should be performed prior and at the end of thetreatment with cardiotoxic drugs. Pacients with slightest clinical, laboratory or echocardiographic parameters of developing heart failure should immediately be reffered to a cardiologist to start with appropriate treatment

Downloads

Download data is not yet available.
Published
2008-04-01
How to Cite
1.
Dolenc J, Koželj M, Zver S. MANAGEMENT OF HAEMATOLOGICAL PATIENTS TREATED WITHCARDIOTOXIC DRUG. ZdravVestn [Internet]. 1Apr.2008 [cited 22Aug.2019];77(SUPPI). Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/523
Section
Article

Most read articles by the same author(s)

1 2 > >>